139 related articles for article (PubMed ID: 25979627)
1. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside-attenuates LPS/D-Gal-induced acute hepatitis in mice.
Zhou D; Ai Q; Lin L; Gong X; Ge P; Che Q; Wan J; Wen A; Zhang L
Innate Immun; 2015 Oct; 21(7):698-705. PubMed ID: 25979627
[TBL] [Abstract][Full Text] [Related]
2. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside alleviated carbon tetrachloride-induced acute hepatitis in mice.
Yang C; Gong X; Ai Q; Ge P; Lin L; Zhang L
Int Immunopharmacol; 2015 Apr; 25(2):393-9. PubMed ID: 25711693
[TBL] [Abstract][Full Text] [Related]
3. AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) increases the production of toxic molecules and affects the profile of cytokines release in LPS-stimulated rat primary microglial cultures.
Łabuzek K; Liber S; Gabryel B; Okopień B
Neurotoxicology; 2010 Jan; 31(1):134-46. PubMed ID: 19853624
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages.
Jhun BS; Jin Q; Oh YT; Kim SS; Kong Y; Cho YH; Ha J; Baik HH; Kang I
Biochem Biophys Res Commun; 2004 May; 318(2):372-80. PubMed ID: 15120611
[TBL] [Abstract][Full Text] [Related]
5. Activation of AMP-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside in the muscle microcirculation increases nitric oxide synthesis and microvascular perfusion.
Bradley EA; Eringa EC; Stehouwer CD; Korstjens I; van Nieuw Amerongen GP; Musters R; Sipkema P; Clark MG; Rattigan S
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1137-42. PubMed ID: 20224051
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
Wang W; Chen J; Li XG; Xu J
Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CYP2E1 induces HepG2 cells death by the AMP kinase activator 5'-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR).
Zhuge J
Cell Biol Toxicol; 2009 Jun; 25(3):253-63. PubMed ID: 18473182
[TBL] [Abstract][Full Text] [Related]
8. LPS inhibits caspase 3-dependent apoptosis in RAW264.7 macrophages induced by the AMPK activator AICAR.
Russe OQ; Möser CV; Kynast KL; King TS; Olbrich K; Grösch S; Geisslinger G; Niederberger E
Biochem Biophys Res Commun; 2014 May; 447(3):520-5. PubMed ID: 24732361
[TBL] [Abstract][Full Text] [Related]
9. AMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injury.
Guo Y; Zhang Y; Hong K; Luo F; Gu Q; Lu N; Bai A
PLoS One; 2014; 9(1):e86881. PubMed ID: 24475189
[TBL] [Abstract][Full Text] [Related]
10. 5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.
Hasenour CM; Ridley DE; Hughey CC; James FD; Donahue EP; Shearer J; Viollet B; Foretz M; Wasserman DH
J Biol Chem; 2014 Feb; 289(9):5950-9. PubMed ID: 24403081
[TBL] [Abstract][Full Text] [Related]
11. Rotenone, a mitochondrial respiratory complex I inhibitor, ameliorates lipopolysaccharide/D-galactosamine-induced fulminant hepatitis in mice.
Ai Q; Jing Y; Jiang R; Lin L; Dai J; Che Q; Zhou D; Jia M; Wan J; Zhang L
Int Immunopharmacol; 2014 Jul; 21(1):200-7. PubMed ID: 24830863
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the TNF-α-induced serine phosphorylation of IRS-1 at 636/639 by AICAR.
Shibata T; Takaguri A; Ichihara K; Satoh K
J Pharmacol Sci; 2013; 122(2):93-102. PubMed ID: 23698110
[TBL] [Abstract][Full Text] [Related]
13. [AMPK activator down-regulates the expression of tissue factor in fulminant hepatitis mice].
Dai J; Lin L; Zhou D; Ai Q; Ge P; Zhang L
Sheng Li Xue Bao; 2016 Feb; 68(1):35-40. PubMed ID: 26915320
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet effect of AMP-activated protein kinase activator and its potentiation by the phosphodiesterase inhibitor dipyridamole.
Liu Y; Oh SJ; Chang KH; Kim YG; Lee MY
Biochem Pharmacol; 2013 Oct; 86(7):914-25. PubMed ID: 23876340
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase.
Kuo CL; Ho FM; Chang MY; Prakash E; Lin WW
J Cell Biochem; 2008 Feb; 103(3):931-40. PubMed ID: 17615555
[TBL] [Abstract][Full Text] [Related]
16. Endogenous AMPK acts as a detrimental factor in fulminant hepatitis via potentiating JNK-dependent hepatocyte apoptosis.
Hu K; Gong X; Ai Q; Lin L; Dai J; Cai L; Jiang R; Ge P; Zhang L
Cell Death Dis; 2017 Mar; 8(3):e2637. PubMed ID: 28252653
[TBL] [Abstract][Full Text] [Related]
17. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
18. AICAR Enhances the Phagocytic Ability of Macrophages towards Apoptotic Cells through P38 Mitogen Activated Protein Kinase Activation Independent of AMP-Activated Protein Kinase.
Quan H; Kim JM; Lee HJ; Lee SH; Choi JI; Bae HB
PLoS One; 2015; 10(5):e0127885. PubMed ID: 26020972
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D.
Zang Y; Yu LF; Nan FJ; Feng LY; Li J
J Biol Chem; 2009 Mar; 284(10):6175-84. PubMed ID: 19144636
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway.
Peng X; Yang Y; Tang L; Wan J; Dai J; Li L; Huang J; Shen Y; Lin L; Gong X; Zhang L
Biomed Pharmacother; 2020 May; 125():110020. PubMed ID: 32106375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
